Business Description
Bayer AG
ISIN : DE000BAY0017
Compare
Compare
Traded in other countries / regions
BAYN.GermanyBAYRY.USA0P6S.UK1BAYN.ItalyBAYN.AustriaBAYN.RomaniaBAYER.HungaryBAY.PolandBAYN.ArgentinaBAYN.Mexico IPO Date
2009-09-21Description
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.3 | |||||
| Debt-to-EBITDA | 4.11 | |||||
| Interest Coverage | 3.93 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.7 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.8 | |||||
| 3-Year EPS without NRI Growth Rate | 8.5 | |||||
| 3-Year FCF Growth Rate | -1.6 | |||||
| 3-Year Book Growth Rate | 2.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -3.36 | |||||
| Future 3-5Y Total Revenue Growth Rate | -0.66 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.14 | |||||
| 9-Day RSI | 35.7 | |||||
| 14-Day RSI | 39.17 | |||||
| 6-1 Month Momentum % | -38.74 | |||||
| 12-1 Month Momentum % | -57.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 254.23 | |||||
| Days Sales Outstanding | 89.59 | |||||
| Days Payable | 124.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 9.14 | |||||
| Dividend Payout Ratio | 16 | |||||
| 3-Year Dividend Growth Rate | -5 | |||||
| Forward Dividend Yield % | 0.42 | |||||
| 5-Year Yield-on-Cost % | 6.82 | |||||
| Shareholder Yield % | 2.94 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.54 | |||||
| Operating Margin % | 16.87 | |||||
| Net Margin % | -6.17 | |||||
| FCF Margin % | 4.97 | |||||
| ROE % | -8.04 | |||||
| ROA % | -2.43 | |||||
| ROIC % | 13.55 | |||||
| ROC (Joel Greenblatt) % | 3.1 | |||||
| ROCE % | 0.48 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 5.03 | |||||
| PE Ratio without NRI | 174.12 | |||||
| Shiller PE Ratio | 10.62 | |||||
| Price-to-Owner-Earnings | 13.26 | |||||
| PS Ratio | 0.54 | |||||
| PB Ratio | 0.77 | |||||
| Price-to-Free-Cash-Flow | 10.84 | |||||
| Price-to-Operating-Cash-Flow | 5.02 | |||||
| EV-to-EBIT | 136.62 | |||||
| EV-to-Forward-EBIT | 26.45 | |||||
| EV-to-EBITDA | 5.56 | |||||
| EV-to-Forward-EBITDA | 9.07 | |||||
| EV-to-Revenue | 1.21 | |||||
| EV-to-Forward-Revenue | 1.24 | |||||
| EV-to-FCF | 24.84 | |||||
| Price-to-Projected-FCF | 0.41 | |||||
| Price-to-Median-PS-Value | 0.34 | |||||
| Earnings Yield (Greenblatt) % | 0.73 | |||||
| FCF Yield % | 9.17 | |||||
| Forward Rate of Return (Yacktman) % | 17.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bayer AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 47,637 | ||
| EPS (TTM) (€) | -2.99 | ||
| Beta | 1.54 | ||
| Volatility % | 30.39 | ||
| 14-Day RSI | 39.17 | ||
| 14-Day ATR (€) | 0.865058 | ||
| 20-Day SMA (€) | 27.213625 | ||
| 12-1 Month Momentum % | -57.57 | ||
| 52-Week Range (€) | 24.955 - 61.45 | ||
| Shares Outstanding (Mil) | 982.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bayer AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bayer AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bayer AG Frequently Asked Questions
What is Bayer AG(LTS:0P6S)'s stock price today?
The current price of LTS:0P6S is €26.27. The 52 week high of LTS:0P6S is €61.45 and 52 week low is €24.96.
When is next earnings date of Bayer AG(LTS:0P6S)?
The next earnings date of Bayer AG(LTS:0P6S) is 2024-05-10 Est..
Does Bayer AG(LTS:0P6S) pay dividends? If so, how much?
The Dividend Yield %  of Bayer AG(LTS:0P6S) is 9.14% (As of Today), Highest Dividend Payout Ratio of Bayer AG(LTS:0P6S) was 16. The lowest was 0.41. And the median was 0.54. The  Forward Dividend Yield % of Bayer AG(LTS:0P6S) is 0.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers